Why it matters: The first AI designed drug has reached human trials. Discover how ISM001-055, Isomorphic Labs, and 200+ AI candidates are reshaping pharma forever.
Why it matters: How AI is reshaping the role of scientific research and discovery in 2026: AlphaFold, GNoME, GraphCast, autonomous labs, plus real reproducibility risks.
Why it matters: AI-driven healthcare innovations in 2026: what works at scale, what still fails, real ROI, regulation, risks, and the honest playbook for hospitals.
Why it matters: AI drug discovery just delivered its first clinical win. See how AI finds new medicines, the real trials, the failures, and what comes next.
Why it matters: See how AI is reshaping diagnostics, drug discovery, and patient care in 2026. Real case studies, ROI data, and regulatory shifts to know.
Why it matters: See which AI healthcare startups in NYC raised the most, who they serve, and the risks buyers weigh before deploying clinical AI in 2026.